Business Context and Reporting Period
Company: ORAGENICS INC
Filing Type: Form 8-K (Current Report)
Date of Report: November 20, 2006
Reporting Period: Single event date (November 20, 2006)
This filing reports a material corporate event under Item 8.01 (Other Events). The Company announced the acquisition of iviGene on the date of the report.
Key Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity figures. This document serves as a notification of a corporate event rather than a financial statement.
Material Changes
- Acquisition: On November 20, 2006, ORAGENICS INC announced the acquisition of iviGene.
- Reference: Details regarding the transaction are contained in the press release attached as Exhibit 99.1, which is incorporated by reference.
Guidance, Outlook, and Risks
The filing text does not contain specific guidance, outlook, management commentary, risk factors, or contingencies related to the acquisition. Investors are directed to the attached press release (Exhibit 99.1) for further details.
Investor Verification Checklist
- Review the attached press release (Exhibit 99.1) for the specific terms of the iviGene acquisition.
- Verify the financial impact of the acquisition on the Company's balance sheet and future operations.
- Confirm the regulatory status and integration timeline of iviGene.